DGAP-News
Balda AG sells entire operating business, distributions of EUR 2.00 per share, approval by AGM required
DGAP-News: Balda AG / Key word(s): Disposal
Balda AG sells entire operating business, distributions of EUR 2.00
per share, approval by AGM required
23.09.2015 / 13:03
---------------------------------------------------------------------
Bad Oeynhausen, 23 September 2015 - Today, Balda AG concluded a purchase
agreement concerning the sales of its entire operating business for a
purchase price of 62.9 million EUR. The buyers are acquiring companies,
which are managed by investment company Paragon, Munich. The sale comprises
all operational units of the Balda Group, i.e. Balda Medical GmbH & Co. KG,
Bad Oeynhausen, Balda C. Brewer, Inc. and Balda Precision, Inc., both in
California, USA, as well as Balda Medical Systems SRL, Romania and further
assets.
"Within the scope of our dialog with investors and possible cooperation
partners, we have noticed increasing interest in our operational units.
This resulted in specific negotiations, which, ultimately culminated in the
agreement that was signed today", says Oliver Oechsle, sole Management
Board member of Balda AG. "The purchase offer by Paragon Partners did not
only exceed the fair value calculated by external experts but will also
give Balda the opportunity to continue to develop as an individual
company", Oechsle also states.
Paragon Partners is a private and owner-managed investment company, aiming
to sustainably improve the strategic and operating business of its
shareholdings. Paragons founding partner Krischan von Moeller adds: "Under
the successful management team, the Balda Group will continue as an
operational unit in accordance with today's strategic orientation. We will
support Balda to actively make use of growth opportunities in the areas of
medical technology as well as pharmaceutical and, if needed, may provide
further equity for organic and external growth."
Oliver Oechsle says: "By selling the operating business of the Balda Group,
we are creating a significant increase in value for the shareholders. But
not only the shareholders will benefit, also our employees and customers.
Paragon Partners has confirmed that it will maintain the current strategic
orientation and organizational structure and that it will retain all
employees of Balda AG as well as the management. This means stability and
continuity. Balda pursues the goal of continuing to further develop over
the next few years - both organically and strategically so as to achieve an
order of magnitude that will offer us completely new courses of action.
Balda stays Balda!"
All in all, the company receives a gross amount (including profits to be
Bad Oeynhausen, 23 September 2015 - Today, Balda AG concluded a purchase
agreement concerning the sales of its entire operating business for a
purchase price of 62.9 million EUR. The buyers are acquiring companies,
which are managed by investment company Paragon, Munich. The sale comprises
all operational units of the Balda Group, i.e. Balda Medical GmbH & Co. KG,
Bad Oeynhausen, Balda C. Brewer, Inc. and Balda Precision, Inc., both in
California, USA, as well as Balda Medical Systems SRL, Romania and further
assets.
"Within the scope of our dialog with investors and possible cooperation
partners, we have noticed increasing interest in our operational units.
This resulted in specific negotiations, which, ultimately culminated in the
agreement that was signed today", says Oliver Oechsle, sole Management
Board member of Balda AG. "The purchase offer by Paragon Partners did not
only exceed the fair value calculated by external experts but will also
give Balda the opportunity to continue to develop as an individual
company", Oechsle also states.
Paragon Partners is a private and owner-managed investment company, aiming
to sustainably improve the strategic and operating business of its
shareholdings. Paragons founding partner Krischan von Moeller adds: "Under
the successful management team, the Balda Group will continue as an
operational unit in accordance with today's strategic orientation. We will
support Balda to actively make use of growth opportunities in the areas of
medical technology as well as pharmaceutical and, if needed, may provide
further equity for organic and external growth."
Oliver Oechsle says: "By selling the operating business of the Balda Group,
we are creating a significant increase in value for the shareholders. But
not only the shareholders will benefit, also our employees and customers.
Paragon Partners has confirmed that it will maintain the current strategic
orientation and organizational structure and that it will retain all
employees of Balda AG as well as the management. This means stability and
continuity. Balda pursues the goal of continuing to further develop over
the next few years - both organically and strategically so as to achieve an
order of magnitude that will offer us completely new courses of action.
Balda stays Balda!"
All in all, the company receives a gross amount (including profits to be
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte